Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective

Documents similaires

• FRONTIER : FReeStyle Libre system use in Ontario among people with diabetes in the IC / ES database—Evidence from real‐world practice: Patients on basal insulin, glucagon‐like peptide 1 receptor agonist or oral therapies
  par: Alexandria Ratzki‐Leewing, et autres
  Publié: (2025)
• Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal‐bolus insulin therapy
  par: Felix Aberer, et autres
  Publié: (2024)
• A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
  par: Carol Wysham, et autres
  Publié: (2025)
• Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis
  par: Ludovico Di Gioia, et autres
  Publié: (2025)
• Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
  par: Nan Dai, et autres
  Publié: (2024)